Skip to main content
    T

    Tarsus Pharmaceuticals Inc (TARS)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $78.20
    -0.48 (-0.61%)

    Market Cap: $3.88B

    Last updated: Nov 17, 2026 at 4:20 PM ET

    Tarsus Pharmaceuticals Inc (TARS) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Tarsus Pharmaceuticals (TARS) has a latest price of $78.20 on Nov 17, 2026, 14.6% below its 52-week high of $91.53. Its price rose 7.2% over the past 12 months. The month-end price rose 169.6% over the 5 years through Oct 2026, a compound annual rate of 21.9%.

    Price Chart

    From Oct 2020 to Oct 2026, its highest month-end close was $81.88 in Dec 2025 and its lowest $12.57 in Mar 2023, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart TARS with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for TARS.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price rose 6.5%, and over 6 months it rose 27.6%. The month-end price rose 425.6% over the 3 years through Oct 2026, a compound annual rate of 73.9%.

    PeriodChange
    1 month+12.5%
    3 months+6.5%
    6 months+27.6%
    12 months+7.2%
    12 months, with dividends+7.2%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years+425.6%+73.9%
    5 years+169.6%+21.9%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2024, when the price rose 173.4%, and its weakest was 2021, when it fell 45.6%.

    YearCloseChange
    2026 through Oct 2026$74.85-8.6%
    2025$81.88+47.9%
    2024$55.37+173.4%
    2023$20.25+38.1%
    2022$14.66-34.8%
    2021$22.50-45.6%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 5.1% above its 50-day average of $74.42 and 14.8% above its 200-day average of $68.10.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$78.20
    52-week high$91.53-14.6%
    52-week low$53.89+45.1%
    50-day average$74.42+5.1%
    200-day average$68.10+14.8%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 45.1%.

    MeasureValue
    1-year beta0.60
    Largest fall, 1 year-32.0%
    Largest fall, 3 years-45.1%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About TARS

    What is TARS's 1-year price change?

    Tarsus Pharmaceuticals's price rose 7.2% over the past 12 months. With dividends included, the 12-month total return was 7.2%.

    What is TARS's 5-year price change?

    Tarsus Pharmaceuticals's month-end price rose 169.6% over the 5 years through Oct 2026, a compound annual rate of 21.9%. These figures leave out dividends.

    What is TARS's 52-week high and low?

    Tarsus Pharmaceuticals's 52-week high is $91.53 and its 52-week low is $53.89. Its latest price of $78.20 on Nov 17, 2026 is 14.6% below the high.

    What is TARS's beta?

    Tarsus Pharmaceuticals's 1-year beta against the S&P 500 is 0.60, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 32.0%.

    Is the TARS chart free?

    Yes. Advanced Charting for TARS is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.